Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genome-wide analyses of aggressiveness in attention-deficit hyperactivity disorder

  • Brevik, Erlend J.
  • van Donkelaar, Marjolein M. J.
  • Weber, Heike|||0000-0002-9421-1292
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Jacob, Christian P.
  • Rivero, Olga|||0000-0002-2664-4053
  • Kittel-Schneider, Sarah|||0000-0003-3057-6150
  • García-Martinez, Iris|||0000-0001-6656-3322
  • Aebi, Marcel
  • van Hulzen, Kimm
  • Cormand, Bru|||0000-0001-5318-4382
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Reif, Andreas|||0000-0002-0992-634X
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Franke, Barbara|||0000-0003-4375-6572
  • Posserud, Maj-Britt
  • Johansson, Stefan E.|||0000-0002-2298-7008
  • Lundervold, Astri J.|||0000-0002-6819-6164
  • Haavik, Jan|||0000-0001-7865-2808
  • Zayats, Tetyana
Aggressiveness is a behavioral trait that has the potential to be harmful to individuals and society. With an estimated heritability of about 40%, genetics is important in its development. We performed an exploratory genome-wide association (GWA) analysis of childhood aggressiveness in attention deficit hyperactivity disorder (ADHD) to gain insight into the underlying biological processes associated with this trait. Our primary sample consisted of 1,060 adult ADHD patients (aADHD). To further explore the genetic architecture of childhood aggressiveness, we performed enrichment analyses of suggestive genome-wide associations observed in aADHD among GWA signals of dimensions of oppositionality (defiant/vindictive and irritable dimensions) in childhood ADHD (cADHD). No single polymorphism reached genome-wide significance (P < 5.00E-08). The strongest signal in aADHD was observed at rs10826548, within a long noncoding RNA gene (beta = -1.66, standard error (SE) = 0.34, P = 1.07E-06), closely followed by rs35974940 in the neurotrimin gene (beta = 3.23, SE = 0.67, P = 1.26E-06). The top GWA SNPs observed in aADHD showed significant enrichment of signals from both the defiant/vindictive dimension (Fisher's P -value = 2.28E-06) and the irritable dimension in cADHD (Fisher's P -value = 0.0061). In sum, our results identify a number of biologically interesting markers possibly underlying childhood aggressiveness and provide targets for further genetic exploration of aggressiveness across psychiatric disorders.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Preliminary evidence for association of genetic variants in pri-miR-34b/c and abnormal miR-34c expression with attention deficit and hyperactivity disorder

  • Garcia Martínez, I.
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Fadeuilhe, Christian|||0000-0001-5821-347X
  • Cormand, Bru|||0000-0001-5318-4382
  • Casas, M.
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés, M..
Attention deficit and hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder characterized by impairment to sustain attention and inability to control impulses and activity level. The etiology of ADHD is complex, with an estimated heritability of 70-80%. Under the hypothesis that alterations in the processing or target binding of microRNAs (miRNAs) may result in functional alterations predisposing to ADHD, we explored whether common polymorphisms potentially affecting miRNA-mediated regulation are involved in this psychiatric disorder. We performed a comprehensive association study focused on 134 miRNAs in 754 ADHD subjects and 766 controls and found association between the miR-34b/c locus and ADHD. Subsequently, we provided preliminary evidence for overexpression of the miR-34c-3p mature form in peripheral blood mononuclear cells of ADHD subjects. Next, we tested the effect on gene expression of single-nucleotide polymorphisms within the ADHD-associated region and found that rs4938923 in the promoter of the pri-miR-34b/c tags cis expression quantitative trait loci for both miR-34b and miR-34c and has an impact on the expression levels of 681 transcripts in trans, including genes previously associated with ADHD. This gene set was enriched for miR-34b/c binding sites, functional categories related to the central nervous system, such as axon guidance or neuron differentiation, and serotonin biosynthesis and signaling canonical pathways. Our results provide preliminary evidence for the contribution to ADHD of a functional variant in the pri-miR-34b/c promoter, possibly through dysregulation of the expression of mature forms of miR-34b and miR-34c and some target genes. These data highlight the importance of abnormal miRNA function as a potential epigenetic mechanism contributing to ADHD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Exome chip analyses in adult attention deficit hyperactivity disorder

  • Zayats, Tetyana
  • Jacobsen, K. K.
  • Kleppe, R.
  • Jacob, Christian P.
  • Kittel-Schneider, Sarah|||0000-0003-3057-6150
  • Ribasés, M..
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Mota, N. R.
  • Grevet, Eugenio Horacio
  • Klein, M.
  • Corominas Galbany, Jordi|||0000-0003-1736-1278
  • Bralten, Janita|||0000-0003-1440-8675
  • Galesloot, Tessel E.
  • Vasquez, A. A.
  • Herms, Stefan|||0000-0002-2786-8200
  • Forstner, A. J.
  • Larsson, Henrik
  • Breen, G.
  • Asherson, Philip|||0000-0003-2667-2254
  • Gross-Lesch, S.
  • Lesch, K. P.
  • Cichon, Sven|||0000-0002-9475-086X
  • Gabrielsen, M. B.
  • Holmen, O. L.
  • Bau, Claiton Henrique Dotto
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Kiemeney, L.
  • Faraone, Stephen V.|||0000-0002-9217-3982
  • Cormand, Bru|||0000-0001-5318-4382
  • Franke, Barbara|||0000-0003-4375-6572
  • Reif, Andreas|||0000-0002-0992-634X
  • Haavik, Jan|||0000-0001-7865-2808
  • Johansson, S..
Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable childhood-onset neuropsychiatric condition, often persisting into adulthood. The genetic architecture of ADHD, particularly in adults, is largely unknown. We performed an exome-wide scan of adult ADHD using the Illumina Human Exome Bead Chip, which interrogates over 250 000 common and rare variants. Participants were recruited by the International Multicenter persistent ADHD CollaboraTion (IMpACT). Statistical analyses were divided into 3 steps: (1) gene-level analysis of rare variants (minor allele frequency (MAF)<1%); (2) single marker association tests of common variants (MAF⩾1%), with replication of the top signals; and (3) pathway analyses. In total, 9365 individuals (1846 cases and 7519 controls) were examined. Replication of the most associated common variants was attempted in 9847 individuals (2077 cases and 7770 controls) using fixed-effects inverse variance meta-analysis. With a Bonferroni-corrected significance level of 1.82E-06, our analyses of rare coding variants revealed four study-wide significant loci: 6q22.1 locus (P =4.46E-08), where NT5DC1 and COL10A1 reside; the SEC23IP locus (P =6.47E-07); the PSD locus (P =7.58E-08) and ZCCHC4 locus (P =1.79E-06). No genome-wide significant association was observed among the common variants. The strongest signal was noted at rs9325032 in PPP2R2B (odds ratio=0.81, P =1.61E-05). Taken together, our data add to the growing evidence of general signal transduction molecules (NT5DC1, PSD, SEC23IP and ZCCHC4) having an important role in the etiology of ADHD. Although the biological implications of these findings need to be further explored, they highlight the possible role of cellular communication as a potential core component in the development of both adult and childhood forms of ADHD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan

  • Franke, Barbara|||0000-0003-4375-6572
  • Michelini, Giorgia
  • Asherson, Philip|||0000-0003-2667-2254
  • Banaschewski, Tobias
  • Bilbow, Andrea
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Cormand, Bru|||0000-0001-5318-4382
  • Faraone, Stephen V.|||0000-0002-9217-3982
  • Ginsberg, Ylva
  • Haavik, Jan|||0000-0001-7865-2808
  • Kuntsi, Jonna|||0000-0002-0113-8162
  • Larsson, Henrik
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Réthelyi, János M.
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Reif, Andreas|||0000-0002-0992-634X
Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder does not remit in puberty, but persists into adulthood. Both in childhood and adulthood, ADHD is characterised by substantial comorbidity including substance use, depression, anxiety, and accidents. However, course and symptoms of the disorder and the comorbidities may fluctuate and change over time, and even age of onset in childhood has recently been questioned. Available evidence to date is poor and largely inconsistent with regard to the predictors of persistence versus remittance. Likewise, the development of comorbid disorders cannot be foreseen early on, hampering preventive measures. These facts call for a lifespan perspective on ADHD from childhood to old age. In this selective review, we summarise current knowledge of the long-term course of ADHD, with an emphasis on clinical symptom and cognitive trajectories, treatment effects over the lifespan, and the development of comorbidities. Also, we summarise current knowledge and important unresolved issues on biological factors underlying different ADHD trajectories. We conclude that a severe lack of knowledge on lifespan aspects in ADHD still exists for nearly every aspect reviewed. We encourage large-scale research efforts to overcome those knowledge gaps through appropriately granular longitudinal studies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing

  • Corominas Galbany, Jordi|||0000-0003-1736-1278
  • Klein, Marieke|||0000-0001-8784-5679
  • Zayats, Tetyana
  • Rivero, Olga|||0000-0002-2664-4053
  • Ziegler, Georg C.|||0000-0001-9411-3169
  • Pauper, Marc
  • Neveling, Kornelia
  • Poelmans, Geert
  • Jansch, Charline
  • Svirin, Evgeniy|||0000-0003-3501-574X
  • Geissler, Julia
  • Weber, Heike|||0000-0002-9421-1292
  • Reif, Andreas|||0000-0002-0992-634X
  • Arias-Vásquez, Alejandro|||0000-0002-4786-0169
  • Galesloot, Tessel E.
  • Kiemeney, Lambertus A. L. M.
  • Buitelaar, Jan|||0000-0001-8288-7757
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Cormand, Bru|||0000-0001-5318-4382
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Hveem, Kristian|||0000-0001-8157-9744
  • Gabrielsen, Maiken Elvestad
  • Hoffmann, Per|||0000-0002-6573-983X
  • Cichon, Sven|||0000-0002-9475-086X
  • Haavik, Jan|||0000-0001-7865-2808
  • Johansson, Stefan E.|||0000-0002-2298-7008
  • Jacob, Christian P.
  • Romanos, Marcel
  • Franke, Barbara|||0000-0003-4375-6572
  • Lesch, Klaus-Peter|||0000-0001-8348-153X
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder with a complex genetic background, hampering identification of underlying genetic risk factors. We hypothesized that combining linkage analysis and whole-exome sequencing (WES) in multi-generation pedigrees with multiple affected individuals can point toward novel ADHD genes. Three families with multiple ADHD-affected members (N = 70) and apparent dominant inheritance pattern were included in this study. Genotyping was performed in 37 family members, and WES was additionally carried out in 10 of those. Linkage analysis was performed using multi-point analysis in Superlink Online SNP 1.1. From prioritized linkage regions with a LOD score ≥ 2, a total of 24 genes harboring rare variants were selected. Those genes were taken forward and were jointly analyzed in gene-set analyses of exome-chip data using the MAGMA software in an independent sample of patients with persistent ADHD and healthy controls (N = 9365). The gene-set including all 24 genes together, and particularly the gene-set from one of the three families (12 genes), were significantly associated with persistent ADHD in this sample. Among the latter, gene-wide analysis for the AAED1 gene reached significance. A rare variant (rs151326868) within AAED1 segregated with ADHD in one of the families. The analytic strategy followed here is an effective approach for identifying novel ADHD risk genes. Additionally, this study suggests that both rare and more frequent variants in multiple genes act together in contributing to ADHD risk, even in individual multi-case families.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder

  • Pagerols, Mireia|||0000-0003-0856-6247
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Rovira, Paula|||0000-0003-2177-8412
  • Soler Artigas, María|||0000-0002-3213-1107
  • García-Martinez, Iris|||0000-0001-6656-3322
  • Calvo-Sánchez, Eva|||0000-0001-8211-6047
  • Corrales, Montserrat|||0000-0002-7428-1402
  • da Silva, Bruna Santos
  • Mota, Nina Roth
  • Moraes Victor, Marcelo
  • Rohde, Luis Augusto
  • Grevet, Eugenio Horacio
  • Bau, Claiton Henrique Dotto
  • Cormand, Bru|||0000-0001-5318-4382
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Methylphenidate (MPH) is the most frequently used pharmacological treatment in children with attention-deficit/hyperactivity disorder (ADHD). However, a considerable interindividual variability exists in clinical outcome. Thus, we performed a genome-wide association study of MPH efficacy in 173 ADHD paediatric patients. Although no variant reached genome-wide significance, the set of genes containing single-nucleotide polymorphisms (SNPs) nominally associated with MPH response (P < 0.05) was significantly enriched for candidates previously studied in ADHD or treatment outcome. We prioritised the nominally significant SNPs by functional annotation and expression quantitative trait loci (eQTL) analysis in human brain, and we identified 33 SNPs tagging cis -eQTL in 32 different loci (referred to as eSNPs and eGenes, respectively). Pathway enrichment analyses revealed an over-representation of genes involved in nervous system development and function among the eGenes. Categories related to neurological diseases, psychological disorders and behaviour were also significantly enriched. We subsequently meta-analysed the association with clinical outcome for the 33 eSNPs across the discovery sample and an independent cohort of 189 ADHD adult patients (target sample) and we detected 15 suggestive signals. Following this comprehensive strategy, our results provide a better understanding of the molecular mechanisms implicated in MPH treatment effects and suggest promising candidates that may encourage future studies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder

  • García-Martinez, Iris|||0000-0001-6656-3322
  • Sánchez-Mora, Cristina|||0000-0003-4211-1107
  • Soler Artigas, María|||0000-0002-3213-1107
  • Rovira, Paula|||0000-0003-2177-8412
  • Pagerols, Mireia|||0000-0003-0856-6247
  • Corrales, Montserrat|||0000-0002-7428-1402
  • Calvo-Sánchez, Eva|||0000-0001-8211-6047
  • Richarte, Vanesa|||0000-0001-7327-318X
  • Bustamante, Mariona|||0000-0003-0127-2860
  • Sunyer, Jordi
  • Cormand, Bru|||0000-0001-5318-4382
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés Haro, Marta|||0000-0003-1039-1116
Attention Deficit Hyperactivity Disorder (ADHD) is a common childhood-onset neurodevelopmental condition characterized by pervasive impairment of attention, hyperactivity, and/or impulsivity that can persist into adulthood. The aetiology of ADHD is complex and multifactorial and, despite the wealth of evidence for its high heritability, genetic studies have provided modest evidence for the involvement of specific genes and have failed to identify consistent and replicable results. Due to the lack of robust findings, we performed gene-wide and pathway enrichment analyses using pre-existing GWAS data from 607 persistent ADHD subjects and 584 controls, produced by our group. Subsequently, expression profiles of genes surpassing a follow-up threshold of P-value < 1e-03 in the gene-wide analyses were tested in peripheral blood mononucleated cells (PBMCs) of 45 medication-naive adults with ADHD and 39 healthy unrelated controls. We found preliminary evidence for genetic association between RNF122 and ADHD and for its overexpression in adults with ADHD. RNF122 encodes for an E3 ubiquitin ligase involved in the proteasome-mediated processing, trafficking, and degradation of proteins that acts as an essential mediator of the substrate specificity of ubiquitin ligation. Thus, our findings support previous data that place the ubiquitin-proteasome system as a promising candidate for its involvement in the aetiology of ADHD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association of the PLCB1 gene with drug dependence

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Roncero, Carlos|||0000-0003-1421-7385
  • Pineda-Cirera, Laura|||0000-0002-4701-7657
  • Palma-Álvarez, Raúl Felipe|||0000-0002-6428-9865
  • Ros-Cucurull, Elena
  • Grau-López, Lara|||0000-0003-1297-1819
  • Esojo, Abderaman|||0000-0003-4669-1639
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Arenas Solà, Concepción|||0000-0002-6489-4934
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Fernàndez-Castillo, Noèlia|||0000-0001-9948-0312
  • Cormand, Bru|||0000-0001-5318-4382
Genetic factors involved in the susceptibility to drug addiction still remain largely unknown. MiRNAs seem to play key roles in the drug-induced plasticity of the brain that likely drives the emergence of addiction. In this work we explored the role of miRNAs in drug addiction. With this aim, we selected 62 SNPs located in the 3'UTR of target genes that are predicted to alter the binding of miRNA molecules and performed a case-control association study in a Spanish sample of 735 cases (mainly cocaine-dependent subjects with multiple drug dependencies) and 739 controls. We found an association between rs1047383 in the PLCB1 gene and drug dependence that was replicated in an independent sample (663 cases and 667 controls). Then we selected 9 miRNAs predicted to bind the rs1047383 region, but none of them showed any effect on PLCB1 expression. We also assessed two miRNAs binding a region that contains a SNP in linkage disequilibrium with rs1047383, but although one of them, hsa-miR-582, was found to downregulate PLCB1, no differences were observed between alleles. Finally, we explored the possibility that PLCB1 expression is altered by cocaine and we observed a significant upregulation of the gene in the nucleus accumbens of cocaine abusers and in human dopaminergic-like neurons after cocaine treatment. Our results, together with previous studies, suggest that PLCB1 participates in the susceptibility to drug dependence.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Highly Polymorphic Copy Number Variant in the NSF Gene is Associated with Cocaine Dependence

  • Cabana-Domínguez, Judit|||0000-0002-4732-7284
  • Roncero, Carlos|||0000-0003-1421-7385
  • Grau-López, Lara|||0000-0003-1297-1819
  • Rodríguez-Cintas, Laia|||0000-0003-2703-6225
  • Barral, Carmen|||0000-0001-9963-6153
  • Abad, Alfonso Carlos|||0000-0001-5706-7693
  • Erikson, Galina
  • Wineinger, Nathan E.
  • Torrico, Bàrbara
  • Arenas Solà, Concepción|||0000-0002-6489-4934
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Cormand, Bru|||0000-0001-5318-4382
  • Fernàndez-Castillo, Noèlia|||0000-0001-9948-0312
Cocaine dependence is a complex psychiatric disorder involving both genetic and environmental factors. Several neurotransmitter systems mediate cocaine's effects, dependence and relapse, being the components of the neurotransmitter release machinery good candidates for the disorder. Previously, we identified a risk haplotype for cocaine dependence in the NSF gene, encoding the protein N-Ethylmaleimide-Sensitive Factor essential for synaptic vesicle turnover. Here we examined the possible contribution to cocaine dependence of a large copy number variant (CNV) that encompasses part of the NSF gene. We performed a case-control association study in a discovery sample (359 cases and 356 controls) and identified an association between cocaine dependence and the CNV (P = 0.013), that was confirmed in the replication sample (508 cases and 569 controls, P = 7.1e-03) and in a pooled analysis (P = 1.8e-04), with an over-representation of low number of copies in cases. Subsequently, we studied the functional impact of the CNV on gene expression and found that the levels of two NSF transcripts were significantly increased in peripheral blood mononuclear cells (PBMC) along with the number of copies of the CNV. These results, together with a previous study from our group, support the role of NSF in the susceptibility to cocaine dependence.